FDA Unveils Sweeping Plan To Spur Animal, Plant Biotech Innovation

FDA unveiled a sweeping action plan that aims to spur innovation in animal and plant biotechnology and establish the agency as a global leader in the oversight of plant biotechnology by making FDA's relevant regulatory pathways more predictable, efficient and transparent. The agency will craft a Veterinary Innovation Program to guide certain sponsors of new animal drugs; issue new guidance documents to clarify FDA's oversight and regulatory policies for animal and plant biotechnology producers; hold a webinar on the agency’s...